The table below shows ACADIA PHARMACEUTICALS INC's cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Q1 2021
Operating cash flow
$33.98M
$20.32M
$29.08M
-$17.93M
-$76.33M
-$60.15M
Capital expenditure
$5.21M
$0.00
-
-
$0.00
$1.08M
Investing cash flow
$66.28M
-$124.05M
-$14.04M
$192.52M
$131.34M
$30.88M
Dividends paid
-
-
-
-
-
ACAD operating cash flow (10-K history)
ACADIA PHARMACEUTICALS INC reported operating cash flow of $109.84M for fiscal year 2025. That is down 30.4% from $157.72M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from -$208.41M (FY 2016) to $109.84M. Figures come from the company's audited annual reports as filed with the SEC.
